Home

Cancer is a devastating disease. The American Cancer Society estimates that in 2015, almost 1.7 million Americans will receive a diagnosis of cancer, and almost 590,000 individuals will succumb to the disease. Clearly we need to learn more about its causes, its treatment, and its prevention.

The Doctoral Program in Cancer Biology at the University of Michigan is an interdisciplinary program whose goal is to train the next generation of cancer researchers. We achieve this goal by providing students with the knowledge and critical thinking skills that will allow them to tackle the most pressing problems associated with this disease. Drawing on the talents of faculty mentors who are leading experts in the field, together with the substantial resources of the University and its NCI-designated Comprehensive Cancer Center, students pursue dissertation projects at the cutting edge of cancer biology.

News

June 17, 2016

Cancer Biology would like to congratulate and acknowledge the following students on the passing and completion of their prelim exam:

Megan Altemus

Ally Hawkins

Morgan Penny

 

April 29, 2016

Congratulations to Jill Boden for being awarded the Best Poster Award at the 2016 AAP/ASCI/APSA Joint Meeting! The title of her poster was NELF-mediated RNA Polymerase II Pausing Regulates Human Gene Expression.

April 29, 2016

The following Program Members presented at AACR:

 

Megan Altemus - Merajver Lab

"Novel microfluidic blood-brain niche to study breast cancer metastasis to the brain"

Merajver Lab 

"Differential levels of glycogen in breast cancer cell lines: A potential new target"

"Macrophages increase the expression of RhoC in inflammatory breast cancer leading to increased migration"

 

Caroline Arellano-Garcia (Kleer Lab) and Rosa Menjivar (Barald Lab)

Student Caucus Poster Competition

 

Alexander Pearson

"Head and neck patient derived xenografts acquire histopathalogical and growth rate changes over increasing passages"

Poster: "A computational algorithm to predict tumor growth and cancer stem cell proportion in-vitro and in-vivo from single-cell observations"